Cargando…

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose

This study aimed to determine the anti-S (receptor binding protein) RBD IgG antibody titers formed against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and the neutralizing antibody inhibition percentages (nAb IH%) in blood samples taken after two doses of inactive or mRNA-based vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gareayaghi, Nesrin, Demirci, Mehmet, Ozbey, Dogukan, Dasdemir, Ferhat, Dinc, Harika Oyku, Balkan, Ilker Inanc, Saribas, Suat, Saltoglu, Neşe, Kocazeybek, Bekir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609633/ https://www.ncbi.nlm.nih.gov/pubmed/36298537 http://dx.doi.org/10.3390/vaccines10101672

Ejemplares similares

Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
por: Saltoğlu, Neşe, et al.
Publicado: (2022)

The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism
por: Özbey, Doğukan, et al.
Publicado: (2023)

Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
por: Balkan, İlker İnanc, et al.
Publicado: (2022)

Association between human leukocyte antigen gene polymorphisms and multiple EPIYA-C repeats in gastrointestinal disorders
por: Saribas, Suat, et al.
Publicado: (2020)

Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
por: Dinç, Harika Öykü, et al.
Publicado: (2022)

Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection
por: Dinc, Harika Oyku, et al.
Publicado: (2022)

Evaluation of the Diagnostic Performance of a SARS-CoV-2 and Influenza A/B Combo Rapid Antigen Test in Respiratory Samples
por: Dinç, Harika Öykü, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)

Detection of A2143G, A2142C, and A2142G Point Mutations with Real-Time PCR in Stool Specimens from Children Infected with Helicobacter pylori
por: Gareayaghi, Nesrin, et al.
Publicado: (2022)

BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism
por: Zubarioglu, Tanyel, et al.
Publicado: (2023)

A Kikuchi-Fujimoto Disease Case Mimicking T Cell Lymphoma with Prolonged Fever
por: Yadigar, Serap, et al.
Publicado: (2014)

Problems encountered in conventional HIV 1/2 Algorithms: lack of necessity for immunoblot assays to confirm repeated ELISA reactive results
por: Yuksel, Pelin, et al.
Publicado: (2018)

Editorial: Blood microbiota in health and disease
por: Demirci, Mehmet, et al.
Publicado: (2023)

Could Prior COVID-19 Affect the Neutralizing Antibody after the Third BNT162b2 Booster Dose: A Longitudinal Study
por: Erdem, Mustafa Genco, et al.
Publicado: (2023)

Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2023)

Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis
por: Uludokumacı, Seven, et al.
Publicado: (2013)

Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children
por: Gulmez, Ruveyda, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
por: Atahan, Ersan, et al.
Publicado: (2023)

Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers
por: Can, Gunay, et al.
Publicado: (2022)

The Role of Invasive and Non-Invasive Procedures in Diagnosing Fever of Unknown Origin
por: Mete, Bilgul, et al.
Publicado: (2012)

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins
por: Yilmaz, Aysun, et al.
Publicado: (2022)

COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
por: Kara Esen, Beril, et al.
Publicado: (2021)

Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection
por: Uysal, Hayriye Kırkoyun, et al.
Publicado: (2016)

Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
por: Seyahi, Emire, et al.
Publicado: (2021)

Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2
por: Rammauro, Florencia, et al.
Publicado: (2022)

Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
por: Masson, Letícia Carrijo, et al.
Publicado: (2023)

A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
por: Baek, Yae Jee, et al.
Publicado: (2023)

1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
por: Surme, Serkan, et al.
Publicado: (2018)

Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021
por: Fortunato, Francesca, et al.
Publicado: (2023)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
por: Barocci, Simone, et al.
Publicado: (2022)

Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study
por: Işlak Mutcal, Sibel, et al.
Publicado: (2016)

Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children
por: Haslak, Fatih, et al.
Publicado: (2022)

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
por: Behrens, Georg M. N., et al.
Publicado: (2022)

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Tenbusch, Matthias, et al.
Publicado: (2021)

Recurrent Staphylococcus warnerii prosthetic valve endocarditis: A case report and review
por: Arslan, Ferhat, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4dr38ogai7amfhvevurbg93baj